Literature DB >> 11873084

Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy.

Carlo Torti, Andrea Patroni, Carmine Tinelli, Intissar Sleiman, Eugenia Quiros-Roldan, Massimo Puoti, Francesco Castelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11873084     DOI： 10.1097/00126334-200203010-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

1.  Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients.

Authors:  Lisa Kakinami; Michael J Adams; Robert C Block; Susan E Cohn; Benedict Maliakkal; Susan G Fisher
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-10       Impact factor: 2.205

2.  Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

Authors:  M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-26       Impact factor: 3.267

3.  Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.

Authors:  Heidi M Crane; Carl Grunfeld; James H Willig; Michael J Mugavero; Stephen Van Rompaey; Richard Moore; Benigno Rodriguez; Betsy J Feldman; Michael M Lederman; Michael S Saag; Mari M Kitahata
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

4.  Ultrasonographic assessment of lipodystrophy in HIV-1-infected patients.

Authors:  P F Grima; R Chiavaroli; P Grima
Journal:  Radiol Med       Date:  2008-10-25       Impact factor: 3.469

5.  The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population.

Authors:  J E Forrester; B H McGovern; M S Rhee; R K Sterling
Journal:  HIV Med       Date:  2009-06-01       Impact factor: 3.180

6.  Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.

Authors:  Vicente Estrada; Paloma Geijo; Manuel Fuentes-Ferrer; María Luisa García Alcalde; María Rodrigo; María José Galindo; Agustín Muñoz; Pere Domingo; Esteve Ribera; Jaime Cosín; Pompeyo Viciana; Fernando Lozano; Alberto Terrón; Antonio Vergara; Ramón Teira; Josefa Muñoz-Sánchez; Bernardino Roca; Trinitario Sánchez; José López-Aldeguer; Elisabeth Deig; Francisco Vidal; Enric Pedrol; Manuel Castaño-Carracedo; Teresa Puig; Myriam Garrido; Ignacio Suárez-Lozano
Journal:  BMC Womens Health       Date:  2011-08-04       Impact factor: 2.809
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.